RT @BeamMedLTD: The MiniOmni Advantage for Osteoporosis Assessment is based on the same proprietary Sunlight Omnipath™ quantitative ultrasound technology that has been proven in thousands of Sunlight Omnisense i... https://t.co/W9SEwxOMuY
The MiniOmni Advantage for Osteoporosis Assessment is based on the same proprietary Sunlight Omnipath™ quantitative ultrasound technology that has been proven in thousands of Sunlight Omnisense i...https://t.co/W9SEwxOMuY
— BeamMed LTD (@BeamMedLTD) March 29, 2021
from Twitter https://twitter.com/GastonR48222321
March 29, 2021 at 11:38AM
Comentarios
Publicar un comentario